CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Other languages Charles River Laboratories International, Inc. Börse Stuttgart

Equities

RV6

US1598641074

Market Closed - Börse Stuttgart Other stock markets 09:58:08 2024-06-07 am EDT			5-day change	1st Jan Change
199.4 ^EUR	-2.04%		+4.34%	-6.19%

Jun. 07	The job report just threw a spanner in the works
Jun. 07	Mizuho Initiates Charles River Laboratories International With Neutral Rating, $235 Price Target	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Lyft, Amazon, Fedex, Xpo, Vail Resorts, Unilever...	Jun. 07
Charles River Laboratories Opens New Contract Vivarium Space in Massachusetts	Jun. 06
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : American Airlines, Salesforce, Five Below, Tesla, Okta...	Jun. 06
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville	Jun. 06
Charles River Laboratories, Sanofi Collaborating to Develop Non-Animal Virtual Control Groups for Preclinical Trials	Jun. 04
Charles River Laboratories International, Inc. Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development	May. 30
Declaration of Voting Results of Charles River Laboratories International Inc	May. 10
Charles River Laboratories International Q1 Non-GAAP Earnings Rise, Revenue Fall; Maintains Full Year 2024 Earnings Guidance	May. 09
Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	May. 09
Stocks Down Pre-Bell Ahead of Latest Earnings Results; Asia, Europe Churn	May. 09
Charles River Laboratories International, Inc. Revises Financial Guidance for 2024	May. 09
China trade heats up, UK rates in view	May. 09
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids	Apr. 25
Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission	Apr. 24
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing	Apr. 16
Charles River Laboratories International, Inc. and Deciphex Limited Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology	Apr. 11
Charles River Laboratories, Axovia Therapeutics Collaborate on Developing Rare Disease Gene Therapies	Apr. 09
Charles River Laboratories International, Inc. Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics	Apr. 09
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus	Apr. 04
Charles River Laboratories International, Inc. and Ship of Theseus Announces Good Manufacturing Practice Plasmid DNA Contract Development and Manufacturing Organization Agreement	Apr. 04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Charles River Laboratories International, Inc. Börse Stuttgart

Equities

RV6

US1598641074

Other languages

Filters